Discovery of dermorphin-based affinity labels with subnanomolar affinity for mu opioid receptors

Bhaswati Sinha, Zhengyu Cao, Thomas F. Murray, Jane V. Aldrich

Research output: Contribution to journalArticle

9 Scopus citations


A series of potent electrophilic affinity labels (IC50= 0.1-5 nM) containing either a bromoacetamide or isothiocyanate based on the μ opioid receptor (MOR) selective peptide dermorphin were prepared. All four analogues exhibited wash resistant inhibition of [3H]DAMGO binding at subnanomolar to nanomolar concentrations, suggesting that these analogues bind covalently to MOR. To our knowledge, these peptides are the highest affinity peptide-based affinity labels for MOR reported to date.

Original languageEnglish
Pages (from-to)7372-7375
Number of pages4
JournalJournal of Medicinal Chemistry
Issue number23
Publication statusPublished - Dec 10 2009


All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Drug Discovery

Cite this